Results 61 to 70 of about 16,082 (221)

Validation of the 2019 Expert Consensus Algorithm for the Management of Conduction Disturbances After TAVR. [PDF]

, 2021
OBJECTIVES The aim of this study was to validate the 2019 consensus algorithm in a large cohort of contemporary transcatheter aortic valve replacement (TAVR) patients.
Heg, Dik, Bartkowiak, Joanna, Lanz, Jonas, Windecker, Stephan, Praz, Fabien, Malebranche, Daniel, Elsmaan, Mamdouh, Reichlin, Tobias, Okuno, Taishi, Stortecky, Stefan, Ryffel, Christoph, Roten, Laurent, Nozica, Nikolas, Bernhard, Benedikt, Räber, Lorenz, Pilgrim, Thomas   +15 more
core   +4 more sources

Outcomes of surgical versus transcatheter aortic valve replacement in nonagenarians- a systematic review and meta-analysis

Journal of Community Hospital Internal Medicine Perspectives, 2021
Introduction: Since the approval of transcatheter aortic valve replacement (TAVR), nonagenarian group patients are being increasingly considered for TAVR. Therefore, we compared the clinical outcomes of surgical aortic valve replacement (SAVR) vs TAVR in
Azka Latif, Muhammad Junaid Ahsan, Noman Lateef, Vikas Kapoor, Mohsin Mansoor Mirza, Faiz Anwer, Michael Del Core, Arun Kanmantha Reddy   +7 more
doaj   +1 more source

Sleep‐disordered breathing in valvular heart disease: A Modifiable comorbidity

Sleep Research, EarlyView.
Abstract Sleep‐disordered breathing (SDB) is highly prevalent among patients with valvular heart disease (VHD) and is independently associated with adverse clinical outcomes. The two major phenotypes—obstructive sleep apnea (OSA) and central sleep apnea (CSA)—exhibit distinct distributions across VHD subtypes. CSA predominates in severe aortic stenosis,
Wu Juan, Chen Ze, Zhang Qun, Chen Qiuyuan, Su Mei, Zhang Xilong, Ding Ning   +6 more
wiley   +1 more source

Initial experience with transcatheter aortic valve replacement before and after lung transplantCentral MessagePerspective

JTCVS Structural and Endovascular
Objectives: Patients with end-stage lung disease and lung transplant (LTx) recipients are high-risk candidates for surgical aortic valve replacement (AVR). Transcatheter AVR (TAVR) is an established treatment for aortic stenosis.
Mujtaba Mubashir, MD, John O. Barron, MD, Samir Kapadia, MD, Amar Krishnaswamy, MD, Shinya Unai, MD, Kenneth McCurry, MD, Marie Budev, DO, MPH, Grant Reed, MD, Rishi Puri, MD, PhD, Haytham Elgharably, MD, Usman Ahmad, MD, James Yun, MD, PhD   +11 more
doaj   +1 more source

Early Multicenter Outcomes of Dedicated Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device‐Associated Pure Aortic Regurgitation

Artificial Organs, EarlyView.
LVAD‐associated aortic regurgitation impairs circulatory support, with limited surgical and off‐label options. In a multicenter registry (n = 30), the AR‐dedicated JenaValve Trilogy TAVR eliminated AR, achieving 96.7% (29/30) technical success and 93.3% (28/30) device success (VARC‐3), with 3.3% (1/30) 30‐day mortality.
Hristian Hinkov, Sara Yousefzada, Isabell A. Just, Christoph Klein, Evgenij Potapov, Santiago Garcia, Dhairya Patel, Lauren S. Ranard, Arseniy Goncharov, Dean J. Kereiakes, Raj R. Makkar, Torsten P. Vahl, Tanja K. Rudolph, Axel Unbehaun   +13 more
wiley   +1 more source

Room Considerations with TAVR [PDF]

Methodist DeBakey Cardiovascular Journal, 2012
While transcatheter aortic valve replacement is considered a viable alternative to traditional surgery for patients with critical aortic stenosis, it is still a cardiac surgical procedure with a steep learning curve. Space consideration is a key aspect of the procedure's success.
openaire   +2 more sources

TAVR in Nonagenarians

JACC: Asia, 2022
[Figure: see text]
Jonathan Curio, Ozan M. Demir
openaire   +2 more sources

Frailty and Five‐Year Mortality After TAVR in Patients Aged 75 Years and Older

Journal of the American Geriatrics Society, EarlyView.
In patients aged 75 years and older undergoing transcatheter aortic valve replacement, frailty assessed by the Clinical Frailty Scale was the most robust geriatric factor independently associated with five‐year mortality. This study highlights the specific prognostic value of frailty beyond short‐term outcomes.
Jérémie Huet, Mélissa Sabin, Thierry Le Tourneau, Thibaut Manigold, Anne‐Sophie Boureau   +4 more
wiley   +1 more source

Predictors of AKI after TAVR.

, 2021
Predictors of AKI after TAVR.
Patrick Ohlmann (5746850), Hélène Petit-Eisenmann (11255905), Kensuke Matsushita (10314953), Joe Heger (11255902), Antonin Trimaille (11255899), Marion Kibler (11255893), Annie Trinh (11255908), Benjamin Marchandot (10314956), Sebastien Hess (11255887), Laurence Jesel (10314962), Adrien Carmona (11255896), Olivier Morel (502242), Antje Reydel (11255890), Marilou Peillex (11255881), Eric Prinz (11255884)   +14 more
core   +1 more source

Renin–angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival [PDF]

Journal of Cardiovascular and Thoracic Research, 2019
Introduction: Hypertension is common in patients with severe aortic stenosis undertaking transcatheter aortic valve replacement (TAVR). Renin–angiotensin system (RAS) blockade therapy with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin ...
Brent Klinkhammer
doaj   +1 more source